Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Pharmaceutical industry wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Drug discovery wikipedia , lookup
Drug interaction wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Theralizumab wikipedia , lookup
Zoopharmacognosy wikipedia , lookup
“HEPATOPROTECTIVE AND ANTIOXIDANT ACTIVITY OF ALBIZIA LEBBECK LINN ON THIOACETAMIDE INDUCED HEPATOTOXICITY IN RATS” By DHARNENDRA KUMAR B.K B.Pharm M. Pharmacy Dissertation Protocol Submitted to the Rajiv Gandhi University of Health Sciences, Bangalore– 560 041, Karnataka. In partial fulfillment of the requirement for the Degree of MASTER OF PHARMACY IN PHARMACOLOGY Under the Guidance of Mr. JOHN WILKING EINSTEIN M.PHARM [Ph .D] ASSISTANT PROFESSOR Dept. of Pharmacology and Toxicology St. John’s Pharmacy College St. John’s Educational Institutions Bangalore – 560040. 2010-11 RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, BANGALORE, KARNATAKA. ANNEXURE II PROFORMA FOR REGISTRATION OF SUBJECT FOR DISSERTATION DHARNENDRA KUMAR B.K 1. Name of the candidate & Address. POST GRADUATE STUDENT, DEPT OF PHARMACOLOGY AND TOXICOLOGY, ST. JOHN’S PHARMACY COLLEGE, BANGALORE- 560040 St. John’s Pharmacy College 2. Name of the Institution. No 6, 9th cross, 2nd main, Vijayanagar, 2nd stage (Hampinagar), Bangalore- 560040 Tel: 91-80-23300958/23300668 Email: [email protected] 3. Course of the study & subject. Master Of Pharmacy - Pharmacology 4. Date of admission. 25TH-MAY-2009 5. Title of the topic :“HEPATOPROTECTIVE AND ANTIOXIDANT ACTIVITY OF ALBIZIA LEBBECK LINN. ON THIOACETAMIDE INDUCED HEPATOTOXICITY IN RATS.” 6.0 Brief resume of the intended work: 6.1 – Need for the study: Liver diseases such as jaundice, cirrhosis and fatty liver are very common worldwide. There are many factors for the development of these diseases, one of the important factors being the use of drugs.1 Drug-induced liver injury is a major health problem that challenges not only health care professionals but also the pharmaceutical industry and drug regulatory agencies. According to the United States Acute Liver Failure Study Group, drug-induced liver injury accounts for more than 50% of acute liver failure, including hepatotoxicity caused by overdose of acetaminophen (39%) and idiosyncratic liver injury triggered by other drugs (13%). Drugs are an important cause on liver injury. Approximately 75% of the idiosyncratic drug reaction results in liver transplantation (or) death.2 In spite of tremendous advances in pharmaceutical field, there is no satisfactory drug for the treatment of hepatotoxicity. Synthetic drugs used in the treatment of liver diseases are sometimes less effective and cause serious adverse effects. Many formulations containing herbal extracts are sold in the Indian market for liver disorders. But management of liver disorders by a simple and precise herbal drug is still an intriguing problem.3 Therefore it is necessary to search for alternative drugs for the treatment of liver disease in order to replace currently used drugs of doubtful efficacy and safety. Hence world health organization (WHO) is giving stress to develop the herbal medicines for the treatment of hepatotoxicity and there is worldwide trend for use of traditional herbal drugs for the treatment of liver diseases. Albizia lebbeck leaves is said to possess hepatoprotective activity and used in ayurveda and other ancient system of medicine for the treatment of liver diseases4. Hence this study is design to evaluate the hepatoprotective and antioxidant activity of Albizia lebbeck plant extracts in rats. 6.2 -Review of Literature:- Thioacetamide is a weak diuretic and acts by inhibiting carbonic anhydrase enzyme. Major adverse effect of Thioacetamide is hepatotoxicity and Thioacetamide (TAA) administration is an established technique for generating rat models of liver fibrosis and cirrhosis. Oxidative stress is believed to be involved as TAA-induced liver fibrosis is initiated by thioacetamide S-oxide, which is derived from the biotransformation of TAA by the microsomal flavine-adenine dinucleotide (FAD)-containing monooxygense (FMO) and cytochrome P450 systems.5 Kumar et al6 have reported The ethanolic extract of Trianthema portulacastrum L. (Aizoaceae) showed a significant dose dependent protective effect against paracetamol and thioacetamide induced hepatotoxicity in albino rats. Galisteo et al7 have reported the capability of an ethanol extract of Rosmarinus tomentosus to protect rat liver in an experimental model of cirrhosis induced by thioacetamide (TAA) has been evaluated. Various plants are known to possess hepatoprotective activity in animals.8 Although, a big list of hepatoprotective phytomolecules are reported in the scientific literature. silymarin, andrographolide, neoandrographolide, curcumin, picroside, kutkoside, phyllanthin, hypophyllanthin, and glycyrrhizin have largely attracted the scientific community.4 Several multi herbal formulations are available in the market for the treatment of liver diseases.9 Albizia lebbeck (L.) Benth. Belongs to the Family Mimosaceae.10 The leaves contains Alkaloids, kaemferol, quercetin, caffeic acid, mature leaves contain keto acids.11,12 The plant is proved for following activities like Antispermatogenic, Antiandrogenic, Anticonvulsant13, Milk-clotting14,Antibacterial15,Anti-inflammatory16, Antioxidant activities.17 plant is also said to have other activities 11 6.3 – Objective of the Study: Collection and authentication of Albizia lebbeck Linn (Mimosaceae) plant leaves. Extraction of plant material using various solvents of increasing order of polarity ether, alcohol and water. Evaluation of Hepatoprotective activity of Albizia lebbeck extracts. 7.0 Materials and Methods: 7.1 Source of Data: Whole work is planned to generate data from laboratory studies. Experiments are performed as described in reference, experimental studies in journals and in textbooks available with college, IISc library, Bangalore, RGUHS digital library (Helinet). Web sites: www.sciencedirect.com www.ncbi.nlm.nih.gov/pubmed www.google.com www.ijp-online.com www.pubmedcentral.com Will be used to obtain related information regarding this research protocol. 7.2 Method of collection of data: The relevant data whatever related to the study will be collected from the internet. Animal required Species: Age/Weight/Size: Gender: Numbers to be used: 6 animals in each group. : Albino Wistar Rats. : Rats 200±20g. : male. Healthy male Wister rats weighing (200±20g) maintained under controlled temperature at 23°C ± 2°C and a 12 hr light-12 hr dark period will be employed for the experimentation. Animals used for the study will be supplied by the St. Johns Pharmacy College, animal house. Animals will be housed in large spacious polypropylene cages on clean paddy husk bedding during the course of the experimental period. 7.3 Method: Experimental design: Rats will be divided into nine groups, each group consisting of six animals. DRUG Group-1 Saline(2ml/kg) Group-2 Thioacetamide (TAA) (100 mg/kg b. w., s.c.) as a 2% w/v solution in water for injection on day 1st and then normal saline for 21 days Group-3 Thioacetamide (TAA) (100 mg/kg b. w., s.c.) as a 2% w/v solution in water for injection on day 1st and then silymarin (25mg/kg per day, p. o.) for 21 days Group-4 Thioacetamide (TAA) (100 mg/kg b .w., s.c.) as a 2% w/v solution in water for injection on day 1st and then ether extract of A.lebbeck (low dose) for 21 days Group-5 Thioacetamide (TAA) (100 mg/kg b .w., s.c.) as a 2% w/v solution in water for injection on day 1st and then ether extract of A.lebbeck (medium dose) for 21 days Group-6 Thioacetamide (TAA) (100 mg/kg b .w., s.c.) as a 2% w/v solution in water for injection on day 1st and then ethanolic extract of A.lebbeck (low dose) for 21 days Group-7 Thioacetamide (TAA) (100 mg/kg b .w., s.c.) as a 2% w/v solution in water for injection on day 1st and then ethanolic extract of A.lebbeck (medium dose) for 21 days Group-8 Thioacetamide (TAA) (100 mg/kg b .w., s.c.) as a 2% w/v solution in water for injection on day 1st and then aqueous extract of A.lebbeck (low dose) for 21 days Group-9 Thioacetamide (TAA) (100 mg/kg b .w., s.c.) as a 2% w/v solution in water for injection on day 1st and then aqueous extract of A.lebbeck (medium dose) for 21 days At the end of experimental period, all the animals will be sacrificed by cervical dislocation. Blood samples will be collected, allowed to clot. Serum will be separated by centrifuging at 2500 rpm for 15 min and analyzed by auto analyzer by using biochemical kits for the following parameters. (A) Biochemical Parameters. 18, 19 Aspartate amino transferase (AST) Alanine amino transferase (ALT) Alkaline Phosphatase (ALP) Total bilirubin. Total protein. The liver samples will be collected from each animal and morphological changes will be observed. Two lobes of liver will be used for histopathological examination. A 10% of liver homogenate will be prepared and the following antioxidant parameters will be estimated using standard procedure. Lipid peroxidation (LPO). Superoxide dismutase (SOD). Catalase (CAT). Glutathione peroxidase (GPx). Acute oral toxicity study: 20 Acute toxicity studies for the ether, ethanolic and aqueous extract of Albizia lebbeck (L.) DC will be done according to the OECD guidelines No: 423 and low and high dose will be selected for treatment. Statistical analysis: The data obtained will be analyzed using one way ANOVA (Graph pad prism version 5.00 software) followed by suitable post test. Number Of Animals Required Total No. of animals required: No of animals for acute oral toxicity =18 No of animals in each group =06 No of groups =09 Total no. of animals required = (06 × 09) =54+18 =72 7.3 - Does the study require any investigations or interventions to be conducted on Patients or other humans or animals? If so, Please describe briefly. Yes, the experimental models require usage of laboratory animals (Male Wistar rats ). 7.4 – Has ethical clearance been obtained from your Institution in case of 7.3? Yes, ethical clearance has been obtained (copy enclosed). 8.0 List of References:1. Jyothi Y, Jagadish V K, Asad M. Effect of Hexane extract of Boswellia serrata oleogum resinon chemically induced liver damage. Pak J Pharm Sci 2006;19:125-9. 2. Mohamed Saleem TS, Christina AJM, Chidambaranathan N, Ravi V, Gauthaman K. Hepatoprotective activity of Annona squamosa Linn. on experimental animal model. Int J Appl Res Nat Pro 2008;1:1-7. 3. Gupta AK, Misra N. Hepatoprotective Activity of Aqueous Ethanolic Extract of Chamomile capitula in Paracetamol Intoxicated Albino Rats. Am J Pharmacol Toxicol 2006; 1:17-20. 4. Low TY, Leow CK, Salto-Tellez M and Chung CMM. A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 2004;4:3960-74. 5. Madhava CK, Sivaji K, Tulasi RK. Flowering plants of chittoor district Andra Pradesh,published by students offset printers(Tirupati), Ist Edition:552. 6. Kumar G, Banu S, Pappa PV, Sundararajan M, Pandian R. Hepatoprotective activity of Trianthema portulacastrum L. against paracetamol and thioacetamide intoxication in albino rats J Ethnopharmacol 2004;92: 37–40. 7. Galisteo M,Sua RA, Montilla MP, Fernandez MI, Gil A,Navarro MC. Protective effects of Rosmarinus tomentosus ethanol extract on thioacetamide-induced liver cirrhosis in rats. Phytomed 2006; 13:101–8. 8. Sharma B, Sharma U K. Hepatoprotective activity of some indigenous plants. Int J PharmTech Res 2009;1:1330-4. 9. Girish C, Koner BC, Jayanthi S, Rao KR, Rajesh B, Pradhan SC. Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice. . Indian J Med Res 2009;129:569-78. 10. Sasya sampada digitized inventory of plants resources of india[online] 2009 [cited on 2009 Dec 14];[1 screen]. Available from URL.http://221.135.191.194/sasya/showhtml.php?d=html_files/Albizia%20lebbeck1/Al bizia%20lebbeck.htm 11. Prajapati ND, Purohit SS,Sharma AK, Kumar T.A Handbook of Medicinal Plants : A Complete Source Book, publication Agrobios(India),Ist Edition: 26. 12. Yoganarasimhan SN. Medicinal Plants of India:vol:2: 30-1 13. Gupta RS, Kachhawa BS, Chaudhary R. Antispermatogenic, antiandrogenic activities of Albizia lebbeck (L.) Benth bark extract in male albino rats. Phytomed 2006;13:277-83. 14. Egito AS, Girardet JM, Laguna LE, Poirson C, Molle D, Miclo L, et al. Milk-clotting activity of enzyme extracts from sunflower and Albizia seeds and specific hydrolysis of bovine k-casein. Int Dairy J 2007; 17:816-25. 15. Rashid RB, Chowdhury R, Jabber A, Hasan CM, Rashid MA. Constituents of albizzia lebbeck and antibacterial activity of an isolated flavone derivative. Saudi pharm J;2003:11:52-6. 16. Prakash Babu N, Pandikumar P, Ignacimuthu S. Anti-inflammatory activity of Albizia lebbeck Benth, an ethnomedicinal plant, in acute and chronic animal models of inflammation. J Ethnopharmacol 2009;125:356–6. 17. Resmi CR, Venukumar MR, Latha S. Antioxidant activity of Albizzia lebbeck (Linn.)benth. in alloxan diabetic rats. Indian J Physiol Pharmacol 2006;50:297-302. 18. Aftab A, Pillai KK, Abul KN, Shibli JA, Pal SN, Balani DK. Evaluation of hepatoprotective potential of jigrine post-treatment against thioacetamide induced hepatic damage. J Ethnopharmacol 2002;79:35–41. 19. Kumar G, Sharmila Banu G, Vanitha Pappa P, Sundararajan M, Rajasekara Pandian M. Hepatoprotective activity of Trianthema portulacastrum L. against paracetamol and thioacetamide intoxication in albino rats.J Ethnopharmacol 2004;92:37-40. 20. The Organization of Economic Co-Operation and Development (OECD). The OECD Guideline for Testing of Chemicals: 423 Acute Oral Toxicity, OECD, Paris 2001 ;1-14